|
WCOG 2026 | Post-Graduate Course |
|
|
Time (IST) |
Topics |
|
08:45 - 09:00 |
Welcome |
|
09:00 - 10:00 |
Session: |
|
09:00 - 09:15 |
Managing GI Bleeding on
Antiplatelets & Anticoagulants |
|
09:15 - 09:30 |
Topical Hemostatic Agents: How To
Choose Between Powders, Gels & Sealants |
|
09:30 - 09:45 |
GI Bleeding In The Intensive Care
Unit |
|
09:45 - 10:00 |
Q&A |
|
10:00 - 11:00 |
Session: |
|
10:00 - 10:15 |
Holistic Management of Metabolic
Dysfunction-Associated Steatotic Liver Disease |
|
10:15 - 10:30 |
Chronic Hepatitis B: New Targets
and Drugs |
|
10:30 - 10:45 |
Diagnosis and Management of
Hepatocellular Carcinoma in 2026 |
|
10:45 - 11:00 |
Q&A |
|
11:00 - 11:30 |
Nutrition Break |
|
11:30 - 12:30 |
Session: |
|
11:30 - 11:45 |
What is New in Rome V |
|
11:45 - 12:00 |
Pharmacological &
Non-Pharmacological Treatment of Functional Dyspepsia |
|
12:00 - 12:15 |
Post-Infectious Irritable Bowel Syndrome: Epidemiology, Diagnosis & Treatment |
|
12:15 - 12:30 |
Q&A |
|
12:30 - 13:30 |
Session: |
|
12:30 - 12:45 |
Acute Severe Ulcerative Colitis:
Saving the Colon With Timely Interventions |
|
12:45 - 13:00 |
Approach to Refractory IBD
|
|
13:00 - 13:15 |
The Role of Endoscopy in
IBD |
|
13:15 - 13:30 |
Q&A |
|
13:30 - 14:30 |
Lunch |
|
14:30 - 15:30 |
Session: |
|
14:30 - 14:45 |
Mechanisms of Pain in Chronic Pancreatitis: Newer Insights |
|
14:45 - 15:00 |
Reducing Mortality In Severe Acute Pancreatits |
|
15:00 - 15:15 |
Pancreatic Cancer - Surveillance
and Early Detection |
|
15:15 - 15:30 |
Q&A |
|
15:30 - 16:30 |
Session: |
|
15:30 - 15:45 |
Acute Liver Failure: Current Management Strategies |
|
15:45 - 16:00 |
Acute-on-Chronic Liver Failure: Prognosis and Management |
|
16:00 - 16:15 |
Advances and Challenges in Liver
Transplantation |
|
16:15 - 16:30 |
Q&A |
|
16:30 - 17:00 |
Moderators: G N Ramesh, Rajeev Jayadevan, Sujit Choudhary |
|
17:00 - 18:00 |
Session: |
|
17:00 - 17:15 |
Celiac Disease: Current and
Emerging Tests for Diagnosis |
|
17:15 - 17:30 |
Small Intestinal Bacterial
Overgrowth and Non-Celiac Enteropathies |
|
17:30 - 17:45 |
Cascade Approach to Chronic
Diarrhea: WGO Guidelines |
|
17:45 - 18:00 |
Q&A |
|
18:00 |
Closing Remarks |
|
19:00 - 20:00 |
Inaugural Function (Brahmkamal Hall) |
|
20:00 Onwards |
Welcome Dinner |
|
WCOG 2026 Scientific
Program |
|||||||
|
Time (IST) |
Brahmkamal |
Grand Ballroom A |
Grand Ballroom B |
Grand Ballroom C |
Room No 302 |
Room No 304 |
Room No 301 |
|
08:00 - 09:00 |
Endoscopy Video
Digest |
||||||
|
08:00 - 08:08 |
When EDGE Gets Tight:
Modified EDGE in One-Anastomosis Gastric Bypass
|
||||||
|
08:08 - 08:16 |
Beyond The Bile Duct : EUS
Guided Vascular Intervention For Hemobilia
|
||||||
|
08:16 - 08:24 |
Releasing The Wrap: Third
Space Endoscopy to The Rescue For Post-Fundoplication Dysphagia
|
||||||
|
08:24 - 08:32 |
Temporary Biliary Sems
Assisted Management of Refractory High Esophageal Stricture And Maintenance with Self
Dilation |
||||||
|
08:32 - 08:40 |
Rescuing Entrapped Devices:
Perils of Lithotripsy |
||||||
|
08:40 - 08:48 |
LAMS Misdeployment And a
Valiant Rescue |
||||||
|
09:00 - 10:05 |
Orations |
||||||
|
09:00 - 09:20 |
ISG - Presidential
Oration |
||||||
|
09:20 - 09:45 |
WGO - Henry L. Bockus
Lecture |
||||||
|
09:45 - 10:05 |
ISG - CM Habibullah Oration
|
||||||
|
10:00 - 11:00 |
Session: |
||||||
|
10:10 - 10:25 |
Global Burden of
Gastrointestinal and Liver Diseases |
||||||
|
10:25 - 10:40 |
Epidemiology of Digestive
Cancer |
||||||
|
10:40 - 11:00 |
What Can Be Done to Change
The Trends: Awareness, Education, Public Policy |
||||||
|
11:00 - 11:15 |
Breakout |
||||||
|
|
Endoscopy |
Luminal |
Liver |
Pancreas |
IBD |
WGO |
Oral Free Papers |
|
11:15 - 12:15 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
11:15 - 11:30 |
How to Perform a Standardized
Upper GI Endoscopy |
Functional Dyspepsia or
Gastroparesis |
Pathophysiology of MASLD:
Dissecting the Metabolic Dysfunction |
Understanding Pathophysiology
of Acute Pancreatitis: How the Evidence Evolved |
IBD's Global Footprint:
Where Are We Now? |
The Climate Change
Crisis |
11:15 - 11:25 11:25 - 11:35 |
|
11:30 - 11:45 |
Quality Indicators in
Colonoscopy: What Really Matters |
Choosing and Interpreting the
Investigations |
Screening and Risk
Stratification in MASLD |
From Acinar Injury to Organ
Dysfunction: How Does it Happen in Humans? |
Modifiying the Milieu:
Enviromental Triggers You Can Control |
Impact of Climate Change on
Vulnerable Populations |
11:35 - 11:45 11:45 - 11:55 |
|
11:45 - 12:00 |
ERCP Quality
Matrix |
Pharmacological and
Non-Pharmacological Treatment |
Pharmacotherapy in MASLD: How
to Choose a Drug? |
Revisiting the Severity
Classification of the Revised Atlanta Classification |
Eating for Remission:
Evidence-Based Dietary Protocols in Practice |
Approaches to Greening
Endoscopy |
11:55 - 12:05 |
|
12:00 - 12:15 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
|
|
12:15 - 13:15 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
12:15 - 12:30 |
Colorectal Cancer Screening:
Strategies in Resource Limited Settings |
Esophageal Ambulatory
pH-Impedancemetry |
Hepatitis A and E: Current
Situation and New Developments |
Pancreatitis Associated with
Systemic Diseases |
Starting Strong: The
First-Line Advanced Therapy Choice in UC |
State of the Art: Microbiome
and Gut Health |
12:15 - 12:25 12:25 - 12:35 12:35 - 12:45 12:45 - 12:55 12:55 - 13:05 |
|
12:30 - 12:45 |
Risk Assessment of Polyps and
Colorectal Cancer |
Laryngo-Pharyngeal
Reflux |
Hepatitis B Treatment
Guidelines – How Best to Use Them in Daily Practice in Varied Resourced Settings
|
Can We Prevent Pancreatic
Necrosis and Vascular Complications in Acute Pancreatitis ? |
IL-23 Inhibitors : What,
Where and How? |
||
|
12:45 - 13:00 |
Emerging Non-invasive
Biomarkers for Colorectal Cancer Screening |
Treatment with Acid
Suppression Including PCABs |
Challenges in the Global
Elimination of Hepatitis C Virus |
Necrotizing pancreatitis:
Timing,Triage and Treatment |
Raising the Therapeutic
Ceiling : New Insights |
State of the Art:
Helicobacter Pylori Eradication Therapy to Prevent Gastric Cancer |
|
|
13:00 - 13:15 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
13:15 - 14:45 |
|
Lunch Symposium Sun Pharma |
Lunch Symposium Olympus |
||||
|
|
|
13:15 - 13:30 |
13:15 - 13:30 |
||||
|
13:30 - 13:45 |
13:30 - 13:45 |
||||||
|
13:45 - 13:55 |
13:45 - 13:55 |
||||||
|
14:45 - 15:45 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
14:45 - 15:00 |
Indeterminate Biliary
Stricture: Current Standards & New Tools |
Appropriate
Investigations |
Non-Invasive Tests for MetALD
and Alcohol Related Liver Disease |
Optimizing Fluid Management:
Approaches Within and After 48 Hours |
14:45 - 15:15 Panelists: Francis Farraye, Ooi Choon Jin, Bhaskar Kante, David Mathew |
Adult Education |
14:45 - 14:55 14:55 - 15:05 15:05 - 15:15 15:15 - 15:25 15:25 - 15:35 |
|
15:00 - 15:15 |
Management of Malignant Hilar
Obstruction |
Pharmacological and
Non-Pharmacological Treatment |
Next-Gen Therapies for
Alcoholic Hepatitis: Regeneration, Barrier Repair and Precision Immunology |
Managing Pain in Acute
Pancreatitis |
Providing Effective
Feedback |
||
|
15:15 - 15:30 |
ERCP In Altered Anatomy:
Strategy & Troubleshooting |
Global Guidelines |
Liver Transplantion in
Alcohol Related Liver Disease |
International Association of
Pancreatology Guidelines on Management of Acute Pancreatitis |
15:15 - 15:45 Panelists: Francis Farraye, Ooi Choon Jin, Peeyush Kumar, Mridul Mahajan |
Presentation
Skills |
|
|
15:30 - 15:45 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
15:45 - 16:45 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
15:45 - 16:00 |
Gastric Varices: Best
Practices in 2026 |
Neuropsychological Issues in
DGBI |
Management of Non-Responders
to First Line Treatment in Autoimmune Hepatitis |
Diagnosis of Infected
Pancreatic Necrosis |
The Surgeon's Edge:
Timing is Everything |
Small Group
Facilitation |
15:45 - 15:55 15:55 - 16:05 16:05 - 16:15 16:15 - 16:25 16:25 - 16:35 16:35 - 16:45 |
|
16:00 - 16:15 |
Liver Biopsy: EUS vs
Percutaneous vs Transjugular |
Chronic Intestinal
Pseudo-Obstruction |
New Therapies for Primary
Biliary Cholangitis |
Current Therapeutic
Strategies to Manage Infected Necrotizing Pancreatitis |
The Second Act: Preventing
the Return of Crohn's |
Bedside
Teaching |
|
|
16:15 - 16:30 |
EUS-Guided Portal Vein Access
& Emerging Applications |
Approach to Fecal
Incontinence |
Future Treatment Options for
Primary Sclerosing Cholangitis |
Impact and Treatment of MDR
XDR Infection in Acute Necrotizing Pancreatitis |
The Crohn's Stricture
Toolkit: Balancing Medical, Endoscopic And Surgical Intervention |
Teaching a
Skill |
|
|
16:30 - 16:45 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
|
|
16:45 - 17:00 |
|
||||||
|
17:00 - 18:00 |
Session: |
Session: |
Session: |
Session: |
Session: |
Focused Group Meeting (IPC) |
Session: |
|
17:00 - 17:15 |
Endoscopic Closure of Leaks
& Fistulae: Clips to Suturing - A Stepwise Approach |
17:00 - 17:30 |
Novel Biomarkers and Pathways
in DILI: From Mechanistic Insights to Clinical Translation |
Psychological / Behavioural
Issues and Their Management in Chronic Pancreatitis |
Colorectal Surveillance in
IBD : Who, When and How? |
Discussasnts: |
17:00 - 17:10 17:10 - 17:20 17:20 - 17:30 17:30 - 17:40 17:40 - 17:50 17:50 - 18:00 |
|
17:15 - 17:30 |
Regenerative Endoscopy &
Tissue Healing Strategies |
CAM- DILI - Regulate or
Prohibit? Public Health Impact, Evidence Gaps, and Medico-Legal Challenges
|
Fatty Pancreas: Summary of an
International Multidisciplinary Consensus |
Preventing Vascular and
Hematologic Complications |
|||
|
17:30 - 17:45 |
EndoVAC Therapy: Indications,
Technique & Optimization |
17:30 - 18:00 |
Immune-Mediated Liver Injury
from Check-Point Inhibitors (ILICI) |
Genetics of Recurrent Acute
and Chronic Pancreatitis: Guidance for Clinicians |
Uninvited Guests: Identifying
and Managing Opportunistic Infections in IBD |
||
|
17:45 - 18:00 |
Q&A |
Q&A |
Q&A |
Q&A |
|||
|
18:00 - 19:00 |
Session: |
Session: |
Session: |
Session: |
Session: |
Focused Group Meeting (CCFI) |
|
|
18:00 - 18:10 |
Correlation of ileocolonic
wall thickening detected on contrast enhanced computed tomography of abdomen with
ileocolonoscopy in patients presenting with gastrointestinal or systemic symptoms (Abstract
ID: 108) |
Serial serum interleukin-8
trajectories are associated with progression from Helicobacter pylori–associated
precancerous lesions to gastric cancer: A prospective longitudinal cohort study (Abstract
ID: 24) |
Faecal microbiota
transplantation for refractory autoimmune liver disease: gut microbiome restoration,
functional metabolic remodelling- a pilot randomized controlled trial
(Abstract ID: 995) |
Whole Genome Sequencing
Unravels The Transmission Landscape Of Pathogenic Bacteria From The Gut And Oral Cavity To
Infected Pancreatic Necrosis Pancreatitis (Abstract ID: 1090) |
Efficacy of a Plant-Based
Diet for Maintaining Remission in Ulcerative Colitis and Its Impact on Gut Microbiome
Restructuring: A 12-Month Randomised Controlled Trial (Abstract ID: 1060) |
Discussasnts: |
|
|
18:10 - 18:20 |
Comparison Of Adequacy Of Eus
Guided Liver Biopsy Withpercutaneous Liver Biopsy In Live Porcine Model (Abstract ID:
730) |
Clinicopathological and
Survival Correlation of Immunohistochemistry and In-Situ Hybridisation-Based Molecular
Classification of Gastric Cancer (Abstract ID: 100) |
Real-world performance of
large language models against multidisciplinary team decisions for hepatocellular carcinoma
(Abstract ID: 392)
|
Beyond Diagnosis: Admission
Lipase Predicts Persistent Organ Failure in Hypertriglyceridemia-Associated Acute
Pancreatitis (Abstract ID: 849) |
Diagnostic value of
ultrasound indices and contrast-enhanced ultrasound for assessing inflammatory bowel disease
activity (Abstract ID: 353)
|
||
|
18:20 - 18:30 |
Endoscopic Findings in
Uninvestigated Dyspepsia With or Without Alarming Symptoms: Should All Patients Referred to
a Gastroenterologist Undergo Upper Gastrointestinal Endoscopy? (Abstract ID:
489) |
Diagnostic Performance Of A
Tegoprazan Based Therapeutic Trial In Patients With Suspected Gerd: Interim Analysis Of The
Prospective Multicenter Phase Iv Tego-Test Study. (Abstract ID: 247)
|
Apixaban prevents hepatic
decompensations in patients with cirrhosis (ApiHep): A randomised controlled trial (Abstract
ID: 959)
|
A Distinct High-risk Subgroup
of Complicated Acute Necrotizing Pancreatitis Qualify as Severe Pancreatitis: A Dual-Centre
Study of 1383 Patients (Abstract ID: 1086)
|
Efficacy and Tolerability of
Amitriptyline in Mild-to-moderate Ulcerative Colitis: A Double-blind Randomized Placebo
Controlled Trial (Abstract ID: 1037)
|
||
|
18:30 - 18:40 |
Towards an Ingestible
Pill-like Microdevice for Non-invasive Sampling of the Microbiome and Biomolecules in the
Upper GI Tract (Abstract ID: 564) |
Indian Ethnicity-Specific
Multi-Omic Landscape of Colorectal Cancer: Novel Signatures, Drivers, and Therapeutic
Targets (Abstract ID: 1016) |
"STING protein is associated
with an immune-cold hepatocellular carcinoma phenotype independent
of disease etiology (Abstract ID: 1014)"
|
Population-based Estimates of
the Prevalence and Risk Factors of Chronic Pancreatitis in India: a Nationwide Prospective
Study (Abstract ID: 1118)
|
Smarter, Not Heavier:
High-Fidelity Ulcerative Colitis Severity Assessment on Standard Workstations
(Abstract ID: 399)
|
||
|
18:40 - 18:50 |
A Prospective Multi-Centric
study on efficacy and safety of yoga-based bowel preparation in colonoscopy (Abstract ID:
628)
|
Novel protein-based
non-invasive biomarkers for predicting enteropathy in patients with Celiac Disease (Abstract
ID: 1020)
|
Genomic Profiling of MASLD in
India: Discovery of Susceptibility Variants and Functional Insights for Precision Risk
Stratification (Abstract ID: 1068)
|
Beyond Transmural Drainage:
The Role of ERCP in Defining Pancreatic Duct Anatomy After Endoscopic Drainage of Pancreatic
Fluid Collections (Abstract ID: 1121)
|
Bridging communication and
adherence gaps in inflammatory bowel disease: A qualitative study of an IBD counsellor model
(Abstract ID: 414)
|
||
|
18:50 - 19:00 |
The involvement of
eosinophilic regulatory cells in the development of eosinophilic esophagitis
(Abstract ID: 16)
|
Ex-vivo enteroid model reveal
distinct epithelial regeneration deficits and DNA damage signatures in untreated and
gluten-free diet non-responsive celiac disease patients. (Abstract ID: 1021)
|
Effect of Probiotic Therapy
on Frailty in Patients with Decompensated Cirrhosis: A Randomized Controlled Trial (Abstract
ID: 1107)
|
Bile Mycobiome
Phosphoproteomic and Acetylomic Signatures Reveal Functional Drivers of Gallbladder
Carcinoma (Abstract ID: 1140)
|
Development and Validation of
an FC-Mayo Score: A Non-Invasive Alternative to Endoscopy-Based Disease Activity Assessment
in Ulcerative Colitis (Abstract ID: 444)
|
||
|
19:00 - 20:00 |
Society Award Function |
||||||
|
20:00 Onwards |
Networking & Banquet Dinner |
||||||
|
WCOG 2026 Scientific
Program |
||||||||
|
Time (IST) |
Brahmkamal |
Grand Ballroom A |
Grand Ballroom B |
Grand Ballroom C |
Room No 302 |
Room No 304 |
Room No 301 |
|
|
08:00 - 09:00 |
Gastroenterology
Clinic |
|
Liver Basic Science
Workshop |
|
|
|
|
|
|
Idiopathic CD4
Lymphocytopenia Presenting with Crohn’s-Like Conundrum and Opportunistic
Enteritis |
||||||||
|
Adult-Onset Lymphocytic
(T-cell) Intestinal Leiomyositis Causing Chronic Intestinal Pseudo-Obstruction, with Delayed
Evolution to Disabling Pansclerotic Morphea: A Decade-Long Case Report |
||||||||
|
When A Hepatic Mass Is Not
Cancer: Adult Multisystem Langerhans Cell Histiocytosis Presenting As A Liver Mass And A
Colonic Stricture |
||||||||
|
Double Trouble: A Parasite
with a Hidden Partner |
||||||||
|
09:00 - 10:05 |
Orations |
|||||||
|
09:00 - 09:25 |
WGO - George Brohee Lecture
|
|||||||
|
09:25 - 09:45 |
INASL - Presidential Oration
"Liver Health by 2047: A National Vision for a Viksit Bharat (Developed
India)" |
|||||||
|
09:45 - 10:05 |
INASL - Dr DV Datta Memorial
Oration |
|||||||
|
10:05 - 10:35 |
Masters of WGO Award Ceremony |
|||||||
|
10:35 - 11:00 |
Oration by Nobel
Laureate |
|||||||
|
|
The Greatest Obstacle to
Discovery: The Ilussion of Knowledge |
|||||||
|
11:00 - 11:15 |
Breakout |
|||||||
|
|
LIVER |
Luminal |
Endoscopy |
IBD |
Pancreas |
WGO |
Oral Free Papers |
|
|
11:15 - 12:15 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
|
11:15 - 11:30 |
INASL - Dr SR Naik Memorial
Oration |
Global Epidemiology of H.
Pyori Infections and Implications for Public Health |
Difficult CBD Stones: Modern
Endoscopic Solutions |
Redefining IBD Monitoring
With Ultrasound |
Early Chronic Pancreatitis:
Is The Process Reversible? |
The Burden of Burnout in
Health Care |
11:15 - 11:25 11:25 - 11:35 |
|
|
11:30 - 11:45 |
INASL - Dr BN Tandon Memorial
Oration |
Diagnosis of H. Pylori: When
and How Test for Hp |
Pre-Operative Biliary
Drainage: When & How |
Improving Clinical Decisions
with Modern Endoscopic Tools |
IPC - Dr RK Tandon Oration
"Chronic Pancreatitis and Precursors to Pancreatic Cancer: Pathogenesis and Clinical
Approaches to Early Cancer Detection" |
Strategies to Improve
Wellbeing |
11:35 - 11:45
11:45 - 11:55
|
|
|
11:45 - 12:00 |
INASL - Dr N Madangopalan
Memorial Oration |
Treatment of H. Pylori in
2026 |
Endoscopic Management of
PSC |
Strategies for Achieving
Treatment Goals in IBD |
Managing Pain of Chronic
Pancreatitis in 2026 |
Communication Skills and
Difficult Conversation |
11:55 - 12:05
|
|
|
12:00 - 12:15 |
|
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
12:15 - 13:15 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
|
12:15 - 12:30 |
Assessment of Clinically
Significant Portal Hypertension (CSPH) in 2026 |
Shifts in Gastric Cancer
Epidemiology and Its Implications Worldwide |
Best Techniques for
EUS-Guided Tissue Acquisition |
From Lab to Clinic:
Harnessing Microbiota for Healing |
Pancreatic Neuroendocrine
Tumours (NET) |
Traiblazer Awards
|
12:15 - 12:25
12:25 - 12:35
|
|
|
12:30 - 12:45 |
Beyond Beta-Blockers:
Emerging Therapies and Anticoagulation Strategies |
Enhancing Detection of Early
Gastric Cancer in Resource Constrained Settings |
Approach to the Incidental
Pancreatic Cyst |
The Youngest Patients:
Unravelling VEO-IBD |
IPMN and Pancreatic Cystic
Neoplasms: Summary of Guidelines From Biology To Precision Surgery |
What are the Barriers For a
Female Gastroenterologist and How We Can Change Them? |
12:35 - 12:45
12:45 - 12:55
|
|
|
12:45 - 13:00 |
Factors and Clinical Outcomes
in Cirrhosis Recompensation |
Diagnosis And Management of
Atrophic Gastritis And Intestinal Metaplasia |
EUS Approach to Gallbladder
Disorders |
Precision IBD: Transition
From One-Size-Fits-All to Patient-Centric Care |
Precision Medicine in
Pancreatic Cancer |
Gastroenterology Training:
Challenges and Opportunities For Women |
12:55 - 13:05
|
|
|
13:00 - 13:15 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
Advancing Into Leadership
Roles Q&A |
||
|
13:15 - 14:45 |
||||||||
|
Lunch Symposium
Fujifilm |
Lunch Symposium |
13:15 - 14:15 |
Lunch Symposium Olympus
|
|||||
|
13:15 - 13:25 |
13:15 - 13:30 |
13:15 - 13:30 |
||||||
|
13:25 - 13:35 |
13:30 - 13:45 |
|||||||
|
13:35 - 13:45 |
13:45 - 13:50 |
|||||||
|
(14:00 - 15:00) |
||||||||
|
14:45 - 15:45 |
Session: |
Session: |
Session: |
Session: |
Focused Group Meeting (INASL)
|
Session: |
||
|
14:45 - 15:00 |
Treatment Options For
Refractory Ascites |
Global Epidemiology of Celiac
Disease And Future Projections |
(14:45 - 15:30) |
More Than a Diagnosis: Living
Well with IBD |
Developing a Chemotherapeutic
Molecule for Pancreatic Cancer: Lessons From a Personal Journey |
Discussasnts: |
14:45 - 14:55 14:55 - 15:05
|
|
|
15:00 - 15:15 |
Long-Term Albumin For
Decompensated Cirrhosis |
The Hidden Majority:
Improving Celiac Disease Detection |
Stopping The Spark: The
Future of IBD Prevention |
Multimodality Treatment of
Pancreatic Cancer – Where Are We Now |
15:05 - 15:15 15:15 - 15:25
|
|||
|
15:15 - 15:30 |
Current and Future Management
of HRS-AKI |
Breaking Free: Treatments for
Celiac Disease Beyond Gluten-Free Diet |
Intercepting The Disease:
Strategies for Secondary Prevention |
Radiomics and AI in
Pancreatic Cancer |
15:25 - 15:35
|
|||
|
15:30 - 15:45 |
Q&A |
Q&A |
(15:30 - 16:15)
|
Q&A |
Q&A |
|||
|
15:45 - 16:45 |
Session: |
Session: |
Session: |
Session: |
Focused Group Meeting (INMA)
|
Session: |
||
|
15:45 - 16:00 |
Pathophysiology of Hepatic
Encephalopathy: Beyond Ammonia |
Secretory Diarrhea: An
Investigative Approach |
CCFI
Oration |
Metabolic Red Flags: New
Onset Diabetes, Sarcopenia and Unexplained Weight Loss as Predictors |
Discussasnts: |
15:45 - 15:55
15:55 - 16:05
|
||
|
16:00 - 16:15 |
New Diagnostic Tools and
Biomarkers in Hepatic Encephalopathy |
Global Burden of GI Parasitic
Infection: Impact on Human Health in The 21st century |
(16:15 - 17:00) |
IBD in LIMICs: Challenges and
Opportunities |
Prehabilitation Before
Surgery For Pancreatic Cancer |
16:05 - 16:15
16:15 - 16:25
|
||
|
16:15 - 16:30 |
Minimal Hepatic
Encephalopathy: Treat or Not |
Hospital Acquired
Diarrhea |
CCFI Guidelines: Endoscopy in
IBD |
Surgery for Oligometastatic
Pancreatic Cancer |
16:25 - 16:35
16:35 - 16:45
|
|||
|
16:30 - 16:45 |
Q&A |
Q&A |
Q&A |
Q&A |
|
|||
|
16:45 - 17:00 |
|
|||||||
|
|
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
|
17:00 - 17:15 |
New Strategies For
Surveillance For HCC in Cirrhosis |
Autoimmune and Other
Enteropathies
|
Metabolic Endoscopy: Beyond
Weight Loss |
Latest Guidelines for
Pregnancy and IBD |
Feeding Strategies in The 1st
Week of Acute Pancreatitis |
17:00 - 17:10
17:10 - 17:20
|
17:00 - 17:10
17:10 - 17:20
|
|
|
17:15 - 17:30 |
Staging and Decision Making
For Treatment in HCC |
Defining Intestinal Failure
and Setting Treatment Goals
|
Endoscopic Gastric Remodeling
Techniques |
CCFI Guidelines: Advanced
Therapy for Ulcerative Colitis |
Exocrine And Endocrine
Dysfunction Following Acute Pancreatitis |
17:20 - 17:30
17:30 - 17:40
|
17:20 - 17:30
17:30 - 17:40
|
|
|
17:30 - 17:45 |
Managing Unresectable HCC -
Emerging Options |
Short And Long Term Treatment
Options for Intestinal Failure |
Role of GLP-1 Therapy in
Bariatric Endoscopy |
CCFI Guidelines: Advanced
Therapy for Crohn's Disease |
17:30 -
18:00 |
17:40 - 17:50
|
||
|
17:45 - 18:00 |
Q&A |
Q&A |
Q&A |
Q&A |
||||
|
18:00 - 19:00 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
|
18:00 - 18:15 |
Current and Emerging Concepts
in Diagnosis and Management of PSVD/NCPF |
Eating Disorders
|
Corrosive Strictures:
Endoscopic Strategies |
Increasing your changes of
Acceptance |
Calcium Signalling Within
Acinar Cells |
18:00 - 18:10
18:10 - 18:20
|
18:00 - 18:10
18:10 - 18:20
|
|
|
18:15 - 18:30 |
Management of Budd Chiari
Syndrome: Current Status and Dilemmas |
Impact of Ultra-Processed
Food |
Esophageal Stenting:
Indications & Techniques |
Introduction to Journal of
Clinical Gastroenterology - The WGO Official Journal |
Immunological Mechansisms of
Progression in Chronic Pancreatitis |
18:20 - 18:30
18:30 - 18:40
|
18:20 - 18:30
18:30 - 18:40
|
|
|
18:30 - 18:45 |
Management of Portal Vein
Thrombosis is Cirrhosis |
FODMAP Diet for
DGBI |
Barrett's Esophagus:
Diagnosis and Management |
Use of AI in Research and
Publications ? |
Plasma Metabolite Signatures
in Pancreartic Cancer: Differentiating From Chronic Pancreatitis |
18:40 - 18:50
18:50 - 19:00
|
18:40 - 18:50
18:50 - 19:00
|
|
|
18:45 - 19:00 |
Q&A |
Q&A |
Q&A |
Panel Discussion / Q&A |
Q&A |
|||
|
19:00 - 20:00 |
Session: |
Session: |
||||||
|
19:00 - 19:15 |
Referral for Liver
Transplantation: When is it Too Early and Late? |
19:00 - 19:20 |
||||||
|
19:15 - 19:30 |
Immunosuppressive Strategies
in Liver Transplantation: Tricks of the Trade |
19:20 - 19:40 |
||||||
|
19:30 - 19:45 |
Liver Transplantation for
ACLF - Recent Concepts |
19:40 - 20:00 |
||||||
|
19:45 - 20:00 |
Panel Discussion / Q&A |
|||||||
|
20:00 Onwards |
Dinner |
|||||||
|
WCOG 2026 Scientific
Program |
|||||||
|
Time (IST) |
Brahmkamal |
Grand Ballroom A |
Grand Ballroom B |
Grand Ballroom C |
Room No 302 |
Room No 304 |
Room No 301 |
|
08:00 - 09:00 |
Liver Clinico-Pathological
Conference (CPC) |
||||||
|
08:00 - 08:20 |
Clinical Discussant:
|
||||||
|
08:20 - 08:30 |
Discussion |
||||||
|
08:30 - 08:50 |
Pathology Discussant:
|
||||||
|
08:50 - 09:00 |
Discussion |
||||||
|
09:00 - 10:00 |
Orations |
||||||
|
09:00 - 09:20 |
IPC - Presidential Oration
|
||||||
|
09:20 - 09:40 |
ISG - PN Chuttani Oration "A Story of Unfloding of Celiac Disease: Globally And In India" Govind K Makharia, India |
||||||
|
09:40 - 10:00 |
ISG - Dr Rakesh Tandon
Oration
"Ultra-Processed Foods: Packaging to Pathology" |
||||||
|
10:00 - 11:00 |
Session:
|
||||||
|
10:00 - 10:10 |
Efficacy and safety of
microfragmented autologous adipose tissue transplantation for perianal fistulas in Crohn’s
disease (ATTIC): a phase 3 multicenter randomized controlled trial (Abstract ID:
162) |
||||||
|
10:10 - 10:20 |
Growth Hormone in
Alcohol-Related Hepatitis Improves Clinical Outcomes and Modulates Regenerative-Immune
Pathways: A Randomized Study (Abstract ID: 179) |
||||||
|
10:20 - 10:30 |
A population based
epidemiological study of Inflammatory Bowel Disease in India(Abstract ID:
403) |
||||||
|
10:30 - 10:40 |
Efficacy and Safety of
Magnetic Compression Anastomosis in Complex Biliary Strictures: A Prospective Multicentre
Clinical Study with Short and Long Term Outcomes
(Abstract ID: 518) |
||||||
|
10:40 - 10:50 |
Endoscopic ultrasound-guided
coil and glue embolization versus balloon-occluded retrograde transvenous obliteration for
prevention of rebleeding from gastric varices: A multicentre, randomized controlled trial
(Abstract ID: 864) |
||||||
|
10:50 - 11:00 |
Mapping Microbial Diversity
Across Endogamous India: The Indian Human Microbiome Initiative (Abstract ID:
977) |
||||||
|
11:00 - 11:30 |
Breakout |
||||||
|
|
Luminal |
LIVER |
Endoscopy |
WGO |
Pancreas |
IBD |
Oral Free Papers |
|
11:30 - 12:30 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
|
11:30 - 11:45 |
Esophageal
Disorders |
Cerebral Edema And
Intracranial Pressure Monitoring in ALF |
EUS Guided Biliary Drainage
|
The AI Gastroenterologist: A Chimera or the New Normal in
the Evolving Era of Digestive Healthcare |
Pediatric Acute Pancreatitis:
Special Challenges |
11:30 - 11:40
11:40 - 11:50
|
|
|
11:45 - 12:00 |
Gastroduodenal
Disorders |
Infections in ALF:
Assessment, Prevention, Management |
Disconnected Pancreatic Duct
Syndrome: Diagnosis to Therapy |
Beyond the Buzzwords:
Where AI Is Already Changing GI Practice |
Drug-Induced Pancreatitis:
Truth or myth |
11:50 - 12:00
12:00 - 12:10
|
|
|
12:00 - 12:15 |
Bowel And Anorectal Disorders
|
Novel Strategies To Improve
Outcomes in ALF |
Ampullectomy: Tricks of the
Trade |
Artificial Inteligence in
Endoscopy: Current Evidence, Clinical Utility and Implementation Pathways |
Chronic Pancreatitis and Type
3c Diabetes: Mechanisms and Special Considerations For Management |
12:10 - 12:20
12:20 - 12:30
|
|
|
12:15 - 12:30 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
12:30 - 13:30 |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
Session: |
|
12:30 - 12:45 |
Early-Onset Colorectal
Cancer: An Emerging Global Concern |
ACLF Endotypes and
Trajectories: Toward Global Harmonization and Precision Trials |
POEM and GERD: New Evidence
and Evolving Concepts |
Trust, Risk, and Regulation:
How to Approve AI For Real Patients |
Timing of Cholecystectomy in
Severe Acute Pancreatitis |
12:30 - 12:40
12:40 - 12:50
|
12:30 - 12:40
12:40 - 12:50
|
|
12:45 - 13:00 |
Upper GI Cancer Screening and
Early Detection: Lessons from India |
Ammonia As a Biomarker in
Cirrhosis and ACLF |
G-POEM: Selecting The Right
Responders |
AI in Endoscopy Training:
Promises and Threats, AI in Endoscopy Training |
Early Diagnosis And
Biomarkers Of Gallbladder Cancer |
12:50 - 13:00
13:00 - 13:10
|
12:50 - 13:00
13:00 - 13:10
|
|
13:00 - 13:15 |
Endoscopic Treatment of Upper
GI Neoplasia: Changing Paradigm in 2026 and Beyond |
Advances in Extracorporeal
Liver Systems For ACLF |
Robotic Endoscopy: Are We
Ready for Prime Time? |
AI in Hepatology -
Revolutionizing The Diagnosis and Management |
Incidental Gallbladder Cancer
After Cholecystectomy: Approach To Management |
13:10 - 13:20
13:20 - 13:30
|
13:10 - 13:20
|
|
13:15 - 13:30 |
Q&A |
Q&A |
Q&A |
Q&A |
Q&A |
||
|
13:30 - 14:45 |
13:30 - 14:15 |
||||||
|
14:30 - 15:15 |
|||||||
|
14:45 - 16:00 |
Session: |
15:15 - 16:15 |
14:15 - 15:00 |
14:45 - 15:45 |
Session: |
Session: |
|
|
14:45 - 15:05 |
INMA Presidential Oration
"Disorders of Gut-Brain Interaction & GI Motility In India: The Past, The Present & The
Future" |
15:15 - 15:30 |
Medico Legal Issue in Gastroentrology |
14:45 - 14:55
14:55 - 15:05
|
14:45 - 14:55
14:55 - 15:05
|
||
|
15:05 - 15:25 |
INMA Frontiers in
Neurogastroenterology Oration |
15:30 - 15:45 |
15:00 - 15:45
|
Discussasnts: |
15:05 - 15:15
15:15 - 15:25
|
15:05 - 15:15
15:15 - 15:25
|
|
|
15:25 - 15:40 |
DGBI: Anorectal Pain
Disorders |
15:45 - 16:00 |
15:25 - 15:35
|
15:25 - 15:35
|
|||
|
15:40 - 15:50 |
Q&A |
||||||
|
16:00 - 17:00 |
Valedictory Ceremonies |
||||||
©Copyright WCOG 2026 India. All Rights Reserved